Your request to link to rcsb for BDBM50306682

• 2YFX: structure of l1196m mutant anaplastic lymphoma kinase in complex with crizotinib (10.1021/JM401805H )
• 5AAA: structure of l1198f mutant human anaplastic lymphoma kinase in complex with crizotinib (10.1056/NEJMOA1508887 )
• 5AAC: structure of c1156y mutant human anaplastic lymphoma kinase in complex with crizotinib (10.1056/NEJMOA1508887 )
• 5AAB: structure of c1156y,l1198f mutant human anaplastic lymphoma kinase in complex with crizotinib (10.1056/NEJMOA1508887 )
• 4ANS: structure of l1196m,g1269a double mutant anaplastic lymphoma kinase in complex with crizotinib
• 4ANQ: structure of g1269a mutant anaplastic lymphoma kinase in complex with crizotinib (10.1021/JM401805H )
• 2XP2: structure of the human anaplastic lymphoma kinase in complex with crizotinib (pf-02341066) (10.1021/JM2007613 )
• 2WGJ: x-ray structure of pf-02341066 bound to the kinase domain of c-met (10.1021/JM2007613 )
• 3ZBF: structure of human ros1 kinase domain in complex with crizotinib (10.1056/NEJMOA1215530 )
• 4C9W: crystal structure of nudt1 (mth1) with r-crizotinib (10.1038/NATURE13194 )
• 6IMZ: crystal structure of mth1 in complex with 18-crown-6